{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-013277","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.802285+00:00","generated_at":"2026-05-15T22:56:15.227465+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"BioLife Solutions issues routine investor presentation; no material news disclosed","bullets":["Investor presentation released on March 2, 2026, highlights cell-based therapy solutions.","Presentation available at company's investor relations website.","No financial results, guidance changes, or strategic initiatives included in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-013277","json":"https://secwatch.observer/filing/0001628280-26-013277.json","markdown":"https://secwatch.observer/filing/0001628280-26-013277.md","text":"https://secwatch.observer/filing/0001628280-26-013277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828026013277/0001628280-26-013277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828026013277/blfs-20260302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:56:15.227465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}